Previous 10 | Next 10 |
home / stock / bct:cc / bct:cc news
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies t...
A look at the top 10 most actives in Canada Athabasca Oil Corporation (ATH) rose 4.4% to $4.53 on volume of 16,671,730 shares Bitfarms Ltd. (BITF) fell 1.9% to $4.64 on volume of 16,479,587 shares Manulife Financial Corporation (MFC) rose 8.9% to $33.41 on volume of 14,401,422 shares Ce...
A look at the top 10 most actives in Canada Bitfarms Ltd. (BITF) rose 15.2% to $4.69 on volume of 17,583,238 shares Enbridge Inc. (ENB) fell 2.5% to $45.2 on volume of 9,273,780 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 7.1% to $3.66 on volume of 8,920,485 shares iS...
Disease control rate of 61% observed in evaluable Phase 2 patients treated with the same formulation in BriaCell’s pivotal Phase 3 study Disease control rate of 50% in evaluable patients treated with the Phase 3 formulation who failed prior antibody-drug conjugate (ADC) therapy...
Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platform Bria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic (killer) T cells and natural killer cells Initiation of GMP manufacturing ...
A look at the top 10 most actives in Canada Horizons Cdn Select Universe Bond ETF (HBB) rose 0.7% to $46.87 on volume of 15,668,391 shares FLINT Corp. (FLNT) rose 50.0% to $0.045 on volume of 15,219,473 shares NICAN Limited (NICN) fell 11.5% to $0.115 on volume of 11,487,306 shares ATEX...
Significant reduction of metastatic breast cancer tumor behind-the-eye after only 3 cycles Powerful anti-tumor response associated with reduction in proptosis (eye-bulging) and reduced ocular pain Heavily pre-treated patient had failed 7 prior regimens including ant...
71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT™, alone and in combination with an immune checkpoint inhibitor (CPI) Tumor reductions observed in heavily pretreated patient...
In the subset of Antibody-Drug Conjugate (ADC) refractory patients, Overall Survival (OS) data of BriaCell’s combination regimen exceeded that of similar studies* Progression Free Survival (PFS) was similar or better than last regimen in 40% of the patients highlighting clinica...
VersaBank (VBNK:CA) is expected to report $0.44 for Q4 2023 Genesis Land Development Corp. (GDC:CA) is expected to report for Q2 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2024 Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Diam...
News, Short Squeeze, Breakout and More Instantly...
Briacell Therapeutics Corp. Company Name:
BCT:CC Stock Symbol:
TSXC Market:
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer car...
A look at the top 10 most actives in Canada Lomiko Metals Inc. (LMR) rose 33.3% to $0.02 on volume of 24,169,410 shares Cathedral Energy Services Ltd. (CET) rose 1.1% to $0.92 on volume of 17,093,313 shares iShares S&P/TSX 60 Index ETF (XIU) rose 0.1% to $33.8614 on volume of 16,406,3...
A look at the top 10 most actives in Canada iShares S&P/TSX 60 Index ETF (XIU) rose 0.1% to $33.875 on volume of 6,142,246 shares Global X Nasdaq-100 Index ETF (QQQX) rose 0.0% to $27.63 on volume of 2,519,095 shares SolGold plc Ordinary Shares (SOLG) fell 3.0% to $0.16 on volume of 2...